u/hassan_chowdhury

I am going to push back on this slightly.

Yeah, the NHS waitlist is genuinely two years in most places.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

This is correct. Private and NHS pathways are different.

Which Boots location?

Boots stock is hit-and-miss by location

Adding to this: tier 3 is doing more work than the comment implies.

prior auth criteria are state-specific, step therapy differs

regulatory claims need a citation to the actual rule, not interpretation

the tier 3 pathway is the only free route, it is slow

Yes, exactly this, and it is the bit that took me 28 weeks to accept.

telehealth costs API source plus compounding markup, total varies

This is an urgent-care question wearing a forum question's clothes.

Adding to this: batch is doing more work than the comment implies.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

Disagree. What you are describing is consistent with lean mass, not with what you concluded.

This is the "correlation is mechanism" thing again. You changed three variables at once.

genuine question, not being difficult: how do you know

Adding to this: prior authorization is doing more work than the comment implies.

the method line is doing real work, not just window dressing

sarcopenia is the unsolved question